Decoding methylation patterns in ovarian cancer using publicly available Next-Gen sequencing data

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Network Modeling Analysis in Health Informatics and Bioinformatics

• Publication date

  2018-08-14

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1007/s13721-018-0173-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-Dimensional Finite Element Model to Study Effect of RyR Calcium Channel, ER Leak and SERCA Pump on Calcium Distribution in Oocyte Cell

  2018cited by this paper
• Finite Element Model to Study Calcium Distribution in T Lymphocyte Involving Buffers and Ryanodine Receptors

  2018cited by this paper
• ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells

  2017cited by this paper
• Epigenetics and Its Role in Human Cancer

  2017cited by this paper
• Identification of novel dysregulated key genes in Breast cancer through high throughput ChIP-Seq data analysis

  2017cited by this paper
• Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation

  2016cited by this paper
• Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

  2016cited by this paper
• Novel Roles and Mechanism for Krüppel-like Factor 16 (KLF16) Regulation of Neurite Outgrowth and Ephrin Receptor A5 (EphA5) Expression in Retinal Ganglion Cells*

  2016cited by this paper
• An interactive environment for agile analysis and visualization of ChIP-sequencing data

  2016cited by this paper
• Finite element model to study calcium distribution in oocytes involving voltage gated Ca2+ channel, ryanodine receptor and buffers

  2016cited by this paper
• Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors.

  2016cited by this paper
• One Dimensional Finite Element Model to Study Calcium Distribution in Oocytes in Presence of VGCC, RyR and Buffers

  2015cited by this paper
• FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells

  2015cited by this paper
• YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients

  2014cited by this paper
• DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review)

  2014cited by this paper
• PAX2 Expression in Ovarian Cancer

  2013cited by this paper
• Practical Guidelines for the Comprehensive Analysis of ChIP-seq Data

  2013cited by this paper
• A Generalized Linear Model for Peak Calling in ChIP-Seq Data

  2012cited by this paper
• Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis

  2012cited by this paper
• Fast gapped-read alignment with Bowtie 2

  2012cited by this paper
• Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.

  2012cited by this paper
• Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF.

  2010cited by this paper
• Aberrant DNA methylation in contrast with mutations

  2010cited by this paper
• Differential methylation profile of ovarian cancer in tissues and plasma.

  2009cited by this paper
• Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.

  2009cited by this paper
• Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study.

  2009cited by this paper
• Analyzing biological network parameters with CentiScaPe

  2009cited by this paper
• Model-based Analysis of ChIP-Seq (MACS)

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

  2007cited by this paper
• Genomic patterns of DNA methylation: targets and function of an epigenetic mark.

  2007cited by this paper
• Pax5: the guardian of B cell identity and function

  2007cited by this paper
• Genome-Wide Mapping of in Vivo Protein-DNA Interactions

  2007cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• Epigenetic therapy of cancer: past, present and future

  2006cited by this paper
• Cancer Statistics, 2005

  2005cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• Gene silencing in cancer in association with promoter hypermethylation.

  2003cited by this paper
• Identification and characterization of human PKNOX2, a novel homeobox-containing gene.

  2001cited by this paper
• Methylation matters

  2001cited by this paper
• Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.

  2000cited by this paper
• The Interaction between the Forkhead Thyroid Transcription Factor TTF-2 and the Constitutive Factor CTF/NF-1 Is Required for Efficient Hormonal Regulation of the Thyroperoxidase Gene Transcription*

  1999cited by this paper
• Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics

  1999cited by this paper
• The CA 125 tumour-associated antigen: a review of the literature.

  1989cited by this paper

• Chip-seq and RNA-seq Data for the Identification of Functional Sub-pathways: A Proof of Consept in Lung Cancer

  2020cites this paper
• Chip-seq and gene expression data for the identification of functional sub-pathways: a proof of concept in lung cancer

  2020cites this paper